Citadel Advisors’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,900
| Closed | -$102K | – | 14767 |
|
|
2025
Q1 | $102K | Buy |
38,900
+400
| +1% | +$1.3K | ﹤0.01% | 11423 |
|
|
2024
Q4 | $136K | Buy |
38,500
+18,000
| +88% | +$68.9K | ﹤0.01% | 11027 |
|
|
2024
Q3 | $93.5K | Sell |
20,500
-6,800
| -25% | -$32.9K | ﹤0.01% | 11215 |
|
|
2024
Q2 | $119K | Sell |
27,300
-9,000
| -25% | -$39.5K | ﹤0.01% | 10668 |
|
|
2024
Q1 | $182K | Sell |
36,300
-10,000
| -22% | -$56K | ﹤0.01% | 10466 |
|
|
2023
Q4 | $290K | Buy |
46,300
+8,400
| +22% | +$48.1K | ﹤0.01% | 9228 |
|
|
2023
Q3 | $270K | Sell |
37,900
-20,100
| -35% | -$158K | ﹤0.01% | 9350 |
|
|
2023
Q2 | $591K | Buy |
58,000
+35,600
| +159% | +$372K | ﹤0.01% | 7565 |
|
|
2023
Q1 | $203K | Buy |
22,400
+13,800
| +160% | +$101K | ﹤0.01% | 10159 |
|
|
2022
Q4 | $61.7K | Sell |
8,600
-4,800
| -36% | -$29.3K | ﹤0.01% | 11883 |
|
|
2022
Q3 | $87K | Buy |
+13,400
| New | +$71.6K | ﹤0.01% | 11210 |
|
Citadel Advisors's SCPH Position: Q4 2025 in Review
Citadel Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 157,217 shares — an estimated $891K sold.
Citadel Advisors first reported a position in SCPH in Q2 2018 and held it in 16 quarters. The position peaked at $3.2M in Q2 2024. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Citadel Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 157,217 scPharmaceuticals shares in Q4 2025, an estimated $891K.
- Citadel Advisors first reported a position in scPharmaceuticals in Q2 2018 and held it in 16 quarters.
- Citadel Advisors's scPharmaceuticals position peaked at $3.2M in Q2 2024.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.